Hybribio Limited

Founded by a group of world professors and entrepreneurs from Hong Kong and Mainland China in 2000, Hybribio is devoted to innovation and technology in developing nucleic acid test (NAT) diagnostic Kits for human healthcare. With R & D centers in Hong Kong and Shanghai, manufacturing base in Guangdong, and customer supporting centres in Beijing, Hong Kong and other cities of China, HybriBio is now one of the leading biotech companies in the World that provides cutting edge technology for HPV test in early cervical cancer screening.